Matches in Nanopublications for { ?s ?p "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP548792.RAdbRYEC0aO5UAYYvdqRv1o2SL_KHefAjnL7iQYCOrqFg130_assertion description "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP548792.RAdbRYEC0aO5UAYYvdqRv1o2SL_KHefAjnL7iQYCOrqFg130_provenance.
- NP437024.RAc9CWhxZ3UIU0gMpaZhxR5OUUHVHwmzwwnrZ6WZyIDos130_assertion description "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP437024.RAc9CWhxZ3UIU0gMpaZhxR5OUUHVHwmzwwnrZ6WZyIDos130_provenance.
- NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_assertion description "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP455929.RA6pXCfIATAM9i-ZJHiWRKS3guG0XKDHDk49AvbORZKYc130_provenance.
- NP683187.RACF-nhzxhkYMrwfb3Q17UPv6ACz1sZSP07bxNuR8OsxQ130_assertion description "[The percent of patients who were free of recurrence with ss-blocker therapy was higher and the death rate was lower among LQT1 patients (81% and 4%, respectively) than among LQT2 (59% and 4%, respectively) and LQT3 (50% and 17%, respectively) patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP683187.RACF-nhzxhkYMrwfb3Q17UPv6ACz1sZSP07bxNuR8OsxQ130_provenance.